195 related articles for article (PubMed ID: 3518910)
1. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
[TBL] [Abstract][Full Text] [Related]
2. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
[TBL] [Abstract][Full Text] [Related]
4. A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss.
Batterham MJ; Garsia R
Int J Androl; 2001 Aug; 24(4):232-40. PubMed ID: 11454075
[TBL] [Abstract][Full Text] [Related]
5. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Johansen KL; Mulligan K; Schambelan M
JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metastatic cancer.
Spiers AS; DeVita SF; Allar MJ; Richards S; Sedransk N
J Med; 1981; 12(6):433-45. PubMed ID: 7033426
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancer.
Chlebowski RT; Chlebowski JS; Herrold J; Richardson B; Ali I; Block JB; Oktay E
Am J Clin Oncol; 1985 Apr; 8(2):157-61. PubMed ID: 3914840
[TBL] [Abstract][Full Text] [Related]
8. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
[TBL] [Abstract][Full Text] [Related]
9. Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
Heinonen E; Alanko A; Gröhn P; Rissanen P
Breast Cancer Res Treat; 1985; 5(1):75-80. PubMed ID: 3978249
[TBL] [Abstract][Full Text] [Related]
10. [Hematological toxicity and nandrolone decanoate during polychemotherapy of bronchogenic carcinoma. Preliminary note].
de Sanctis C; De Luca S; Succi A; Gargiulo P; Mugnaini L; Antilli A; Signora M; Cruciani AR
Clin Ter; 1986 Aug; 118(3):183-6. PubMed ID: 3757462
[No Abstract] [Full Text] [Related]
11. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
[TBL] [Abstract][Full Text] [Related]
12. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
Johansen KL; Painter PL; Sakkas GK; Gordon P; Doyle J; Shubert T
J Am Soc Nephrol; 2006 Aug; 17(8):2307-14. PubMed ID: 16825332
[TBL] [Abstract][Full Text] [Related]
13. Nandrolone decanoate reduces the premature mortality of cardiomyopathic hamsters.
Davis WM; Long SF; Lin TL
Res Commun Chem Pathol Pharmacol; 1993 Jul; 81(1):21-32. PubMed ID: 8210687
[TBL] [Abstract][Full Text] [Related]
14. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
Bone; 1989; 10(1):3-6. PubMed ID: 2736154
[TBL] [Abstract][Full Text] [Related]
15. Nandrolone decanoate for men with osteoporosis.
Hamdy RC; Moore SW; Whalen KE; Landy C
Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
[TBL] [Abstract][Full Text] [Related]
16. Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters.
van Balkom RH; Dekhuijzen PN; van der Heijden HF; Folgering HT; Fransen JA; van Herwaarden CL
Eur Respir J; 1999 May; 13(5):1062-9. PubMed ID: 10414405
[TBL] [Abstract][Full Text] [Related]
17. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
[TBL] [Abstract][Full Text] [Related]
18. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
Barton Pai A; Chretien C; Lau AH
Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
[TBL] [Abstract][Full Text] [Related]
19. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
Gennari C; Agnusdei D; Gonnelli S
Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
[TBL] [Abstract][Full Text] [Related]
20. Effects of nandrolone decanoate on bone mass in established osteoporosis.
Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
